GKB Ophthalmics Reports Negative Financial Results
GKB Ophthalmics, a microcap company in the FMCG industry, reported a decline in net sales, consolidated net profit, and operating profit for the quarter ended September 2023. MarketsMojo has given a 'Strong Sell' rating for the stock, citing negative financial performance with a score of -12. However, the company has a high debtors turnover ratio, but its profit before and after tax have significantly decreased compared to previous quarters.
GKB Ophthalmics, a microcap company in the FMCG industry, recently announced its financial results for the quarter ended September 2023. The company's net sales saw a decline of 8.36% compared to the previous quarter, while its consolidated net profit showed a significant decrease of 325.00%. The operating profit (PBDIT) excluding other income also saw a decline of 122.06%, and interest expenses increased by 6.98%.
According to MarketsMOJO, a leading financial analysis platform, the stock call for GKB Ophthalmics is currently 'Strong Sell'. The company's financial performance for the quarter has been negative, with a score of -12 compared to 1 in the previous quarter.
However, there are some positive aspects to GKB Ophthalmics' financials for the quarter. The company's debtors turnover ratio for the last five half-yearly periods has been the highest at 3.66 times, indicating that the company has been able to settle its debtors faster.
On the other hand, there are some concerning factors as well. The profit before tax (PBT) less other income for the quarter has fallen by 144.6% compared to the average PBT of the previous four quarters. The profit after tax (PAT) has also shown a significant decrease of 196.2% compared to the average PAT of the previous four quarters. Additionally, the company's operating cash flow has been consistently falling over the last three years.
Overall, GKB Ophthalmics' financial performance for the quarter ended September 2023 has been negative. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
